CORE--LARGE-SCALE HEMATOPOIETIC CELL PROCESSING RESOURCE

核心--大规模造血细胞处理资源

• 批准号: 7488586
• 负责人: Shelly Heimfeld
• 金额: $ 23.53万
• 依托单位: FRED HUTCHINSON CANCER RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-01 至 2010-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7488586
• 关键词: Address; Aliquot; Allogenic; Am 80; Animal Model; Antigen-Presenting Cells; Antigens; Autoimmune Diseases; B-Lymphocytes; Biological Models; Biology; Blood Cells; Blood Component Removal; Blood Platelets; Bone Marrow; Bone Marrow Transplantation; CD14 gene; CD3 Antigens; CD34 gene; CD8B1 gene; Cancer Center Support Grant; Canis familiaris; Cell Count; Cell Therapy; Cell physiology; Cell surface; Cells; Cellular biology; Charge; Chimerism; Chronic; Clinic; Clinical; Clinical Research; Collection; Commercial Sources; Commit; Computer software; Condition; Confidentiality; Consent; Correlative Study; Cost Savings; Cryopreserved Cell; Cytomegalovirus; Cytotoxic T-Lymphocytes; Data; Databases; Dendritic Cells; Detection; Development; Disease; Documentation; Dose; ES Cell Line; Ectoderm; Embryonic Development; End Point; Endoderm; Fees; Flow Cytometry; Freezing; Funding; Future; Gene Expression; Generations; Genetic; Germ Layers; Graft Rejection; Grant; Harvest; Health; Health Insurance Portability and Accountability Act; Hematopoietic; Homologous Transplantation; Human; Immune; Immunotherapy; In Vitro; Individual; Investigation; Laboratories; Life; Lymphocyte; Lymphocyte Subset; MS4A1 gene; Macaca; Malignant Neoplasms; Mediation; Mesoderm; Modeling; Modification; Molecular Biology; Morbidity - disease rate; NCAM1 gene; Natural Killer Cells; Numbers; Operative Surgical Procedures; Outcome; Patients; Pattern; Peer Review; Peripheral Blood Stem Cell; Population; Price; Primates; Probability; Procedures; Process; Progress Reports; Protocols documentation; Publications; Publishing; Quality Control; Range; Rate; Reagent; Recovery; Regulation; Relapse; Replacement Therapy; Reporting; Repository Operations; Research; Research Activity; Research Ethics Committees; Research Personnel; Research Project Grants; Research Support; Resources; Retroviral Vector; Risk; Rodent; Sampling; Screening procedure; Services; Source; Staining method; Stains; Stem Cell Research; Stem cells; System; T-Cell Depletion; T-Lymphocyte; T-Lymphocyte Subsets; Technology; Testing; Time; Translations; Transplantation; Uridine; Vial device; Work; base; cell bank; cell suicide; cell type; cellular transduction; chronic graft versus host disease; cost; data integration; discount; drug discovery; embryonic stem cell; experience; gene therapy; graft vs host disease; improved; in vivo; instrument; interest; member; model development; monocyte; mortality; neutrophil; novel therapeutics; pre-clinical; preclinical study; progenitor; programs; reactivation from latency; reconstitution; repository; research study; suicide gene; trend; volunteer

ABSTRACT NOT PROVIDED

未提供摘要